Medicina y salud
Disciplina temática
Institute Curie
París, FranciaPublicaciones en colaboración con investigadores/as de Institute Curie (10)
2023
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
2022
-
Six-Year Results from RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma
Journal of Clinical Oncology
-
The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851
2021
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
2019
-
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study
Leukemia and Lymphoma, Vol. 60, Núm. 7, pp. 1803-1811
2017
-
Identification of miRSNPs associated with the risk of multiple myeloma
International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534
2016
-
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis
Oncotarget, Vol. 7, Núm. 37, pp. 59029-59048
2012
-
Independent transcriptional reprogramming and apoptosis induction by cisplatin
Cell Cycle, Vol. 11, Núm. 18, pp. 3472-3480
-
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Cell Reports, Vol. 2, Núm. 2, pp. 257-269